Threshold signaling of human Th0 cells in activation and anergy: Modulation of effector function by altered TCR ligand

Journal of Immunology

Volumn 164, Issue 11, 2000, Pages 6034-6040

  Verhoef, Adrienne ^a   Lamb, Jonathan R ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ALLERGEN; B7 ANTIGEN; CD3 ANTIGEN; CD86 ANTIGEN; EPITOPE; INTERLEUKIN 10; INTERLEUKIN 5;

AMINO ACID SUBSTITUTION; ARTICLE; CLONAL ANERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DERMATOPHAGOIDES PTERONYSSINUS; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; LIGAND BINDING; PRIORITY JOURNAL; T LYMPHOCYTE RECEPTOR GENE;

EID: 0034123138     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.11.6034     Document Type: Article

References (48)

1. Sher, A., and R. L. Coffman. 1992. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu. Rev. Immunol. 10:385.
2. Romagnani, S. 1994. Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. 12:227.
3. O'Garra, A., and K. Murphy. 1994. Role of cytokines in determining T-lymphocyte function. Curr. Opin. Immunol. 6:458.
4. O'Hehir, R. E., R. Busch, J. B. Rothbard, and J. R. Lamb. 1991. An in vitro model of peptide-mediated immunomodulation of the human T cell response to Dermatophagoides spp. (house dust mite). J. Allergy Clin. Immunol. 87:1120.
5. Parronchi, P., D. Macchia, D, M. P. Piccinni, P. Biswas, C. Simonelli, E. Maggi, M. Ricci, A. A. Ansari, and S. Romagnani. 1991. Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc. Natl. Acad. Sci. USA 88:4538.
6. + T lymphocytes in atopic patients. J. Immunol. 144:4651.
7. Bos, J. D., E. A. Wierenga, J. H. Sillevis Smitt, F. L. van der Heijden, and M. L. Kapsenberg. 1992. Immune dysregulation in atopic eczema. Arch. Dermatol. 128:1509.
8. Durham, S. R., S. Ying, V. A. Varney, M. R. Jacobson, R. M. Sudderick, I. S. Mackay, A. B. Kay, and Q. A. Hamid. 1992. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J. Immunol. 148:2390.
9. de Vries, J. E., and G. Zurawski. 1995. Immunoregulatory properties of IL-13: its potential role in atopic disease. Int. Arch. Allergy Immunol. 106:175.
10. Weller, P. F. 1997. Human eosinophils. J. Allergy Clin. Immunol. 100:283.
11. Wierenga, E. A., M. Snoek, J. D. Bos, H. M. Jansen, and M. L. Kapsenberg. 1990. Comparison of diversity and function of house dust mite-specific T lymphocyte clones from atopic and non-atopic donors. Eur. J. Immunol. 20:1519.
12. Akdis, C. A., M. Akdis, T. Blesken, D. Wymann, S. S. Alkan, U. Muller, and K. Blaser. 1996. Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. J. Clin. Invest. 98:1676.
13. + T cells from allergic individuals. J. Exp. Med. 178:2123.
14. Mueller, D. L., M. K. Jenkins, and R. H. Schwartz. 1989. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7:445.
15. Babbitt, B. P., P. M. Allen, G. Matsueda, E. Haber, and E. R. Unanue. 1985. Binding of immunogenic peptides to Ia histocompatibility molecules. Nature 317:359.
16. Evavold, B. D., J. Sloan-Lancaster, B. L. Hsu, and P. M. Allen. 1993. Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides. J. Immunol. 150:3131.
17. Evavold, B. D., and P. M. Allen. 1991. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science 252:1308.
18. Racioppi, L., F. Ronchese, L. A. Matis, and R. N. Germain. 1993. Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling. J. Exp. Med. 177:1047.
19. Pfeiffer, C., J. Stein, S. Southwood, H. Ketelaar, A. Sette, and K. Bottomly. 1995. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J. Exp. Med. 181:1569.
20. Nicholson, L. B., A. Murtaza, B. P. Hafler, A. Sette, and V. K. Kuchroo. 1997. A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigens. Proc. Natl. Acad. Sci. USA 94:9279.
21. Lamb, J. R., B. J. Skidmore, N. Green, J. M. Chiller, and M. Feldmann. 1983. Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin. J. Exp. Med. 157:1434.
22. O'Hehir, R. E., and J. R. Lamb. 1990. Induction of specific clonal anergy in human T lymphocytes by Staphylococcus aureus enterotoxins. Proc. Natl. Acad. Sci. USA 87:8884.
23. Sloan-Lancaster, J., B. D. Evavold, and P. M. Allen. 1993. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature 363:156.
24. Nicholson, L. B., J. M. Greer, R. A. Sobel, M. B. Lees, and V. K. Kuchroo. 1995. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity 3:397.
25. O'Hehir, R. E., A. Verhoef, E. Panagiotopoulou, S. Keswani, J. D. Hayball, W. R. Thomas, and J. R. Lamb. 1993. Analysis of human T cell responses to the group II allergen of Dermatophagoides species: localization of major antigenic sites. J. Allergy Clin. Immunol. 92:105.
26. van Neerven, R. J. J., W. van 't Hof, J. H. Ringrose, H. M. Jansen, R. C. Aalberse, E. A. Wierenga, and M. L. Kapsenberg. 1993. T cell epitopes of house dust mite major allergen Der p II. J. Immunol. 151:2326.
27. Verhoef, A., J. A. Higgins, C. J. Thorpe, S. G. E. Marsh, J. D. Hayball, J. R. Lamb, and R. E. O'Hehir. 1993. Clonal analysis of the atopic immune response to the group 2 allergen of Dermatophagoides spp.: identification of HLA-DR and -DQ restricted T cell epitopes. Int. Immunol. 5:1589.
28. + T cells. J. Immunol. 157:2160.
29. Valitutti, S., S. Muller, M. Cella, E. Padovan, and A. Lanzavecchia. 1995. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 375:148.
30. Hawrylowicz, C. M., E. R. Jarman, L. Guida, R. E. O'Hehir, and J. R. Lamb. 1996. T-cell receptor peptides that inhibit the T-cell response to allergen induce transforming growth factor-β 1 production. J. Allergy Clin. Immunol. 97:707.
31. + T cells. J. Exp. Med. 184:19.
32. Tsitoura, D. C., W. Holter, A. Cerwenka, C. M. Gelder, and J. R. Lamb. 1996. Induction of anergy in human T helper 0 cells by stimulation with altered T cell antigen receptor ligands. J. Immunol. 156: 2801.
33. Evavold, B. D., J. Sloan-Lancaster, and P. M. Allen. 1993. Tickling the TCR: selective T-cell functions stimulated by altered peplide ligands. Immunol. Today 14:602.
34. Carballido, J. M., A. Faith, N. Carballido-Perrig, and K. Blaser. 1997. The intensity of T cell receptor engagement determines the cytokine pattern of human allergen-specific T helper cells. Eur. J. Immunol. 27:515.
35. Harding, C. V., and E. R. Unanue. 1990. Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation. Nature 346: 574.
36. Valitutti, S., and A. Lanzavecchia. 1997. Serial triggering of TCRs: a basis for the sensitivity and specificity of antigen recognition. Immunol. Today 18:299.
37. Nicholson, L. B., H. Waldner, A. M. Carrizosa, A. Sette, M. Collins, and V. K. Kuchroo. 1998. Heteroclitic proliferative responses and changes in cytokine profile induced by altered peptides: implications for autoimmunity. Proc. Natl. Acad. Sci. USA 95:264.
38. Akdis, C. A., T. Blesken, M. Akdis, B. Wuthrich, and K. Blaser. 1998. Role of interleukin 10 in specific immunotherapy. J. Clin. Invest. 102:98.
39. Rizzo, L. V., N. E. Miller Rivero, C. C. Chan, B. Wiggert, R. B. Nussenblatt, and R. R. Caspi. 1994. Interleukin-2 treatment potentiates induction of oral tolerance in a murine model of autoimmunity. J. Clin. Invest. 94:1668.
40. Steinbrink, K., M. Wolfl, H. Jonuleit, J. Knop, and A. H. Enk. 1997. Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 159:4772.
41. Van Parijs, L., M. P. Sethna, A. N. Schweitzer, F. Borriello, A. H. Sharpe, and A. K. Abbas, 1997. Functional consequences of dysregulated B7-1 (CD80) and B7-2 (CD86) expression in B or T lymphocytes of transgenic mice. J. Immunol. 159:5336.
42. Chen, Y., J. I. Inobe, R. Marks, P. Connella, V. K. Kuchroo, and H. L. Weiner. 1995. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 376:177.
43. Windhagen, A., C. Scholz, P. Hollsberg, H. Fukaura, A. Sette, and D. A. Hafler. 1995. Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity 2:373.
44. Tsitoura, D. C., C. M. Gelder, D. M. Kemeny, and J. R. Lamb. 1997. Regulation of cytokine production by human Th0 cells following stimulation with peptide analogues: differential expression of TGF-β in activation and anergy. Immunology 92:10.
45. Matsuoka, T., H. Kohrogi, M. Ando, Y. Nishimura, and S. Matsushita. 1996. Altered TCR ligands affect antigen-presenting cell responses: up-regulation of IL-12 by an analogue peptide. J. Immunol. 157:4837.
46. Ikagawa, S., S. Matsushita, Y. Z. Chen, T. Ishikawa, and Y. Nishimura. 1996. Single amino acid substitutions on a Japanese cedar pollen allergen (Cry j 1)-derived peptide induced alterations in human T cell responses and T cell receptor antagonism. J. Allergy Clin. Immunol. 97:53.
47. Faith, A., C. A. Akdis, M. Akdis, A. Joss, D. Wymann, and K. Blaser. 1999. An altered peptide ligand specifically inhibits Th2 cytokine synthesis by abrogating TCR signaling. J. Immunol. 162:1836.
48. Janssen, E. M., A. J. M van Oosterhout, A. J. M. L. van Rensen, W. van Eden, F. P. Nijkamp, and M. H. M. Wauben. 2000. Modulation of Th2 responses by peptide analogues in a murine model of allergic asthma: amelioration or deterioration of the disease process depends on the Th1 or Th2 skewing characteristics of the therapeutic peptide. J. Immunol. 164:580.